Terkko Navigator / -/ Feeds / " ( ( Founder-ilmiö )|( Founder Effect )|( Effect, Founder )|( Effects, Founder )|( Founde"

Take back your time and attention with digital minimalism

Explosive Weapons: Declaration to Curb Civilian Harm

Eva Augusta Vescelius: Life and Music Career Before 1900

Founder effect of Fabry disease due to p.F113L mutation: Clinical profile of a late-onset phenotype.

Founder effect in spinal and bulbar muscular atrophy (SBMA) in Scandinavia

Founder mutation in myosin-binding protein C with an early onset and a high penetrance in males

Founder effects facilitate the use of a genotyping-based approach to molecular diagnosis in Swedish patients with familial hypercholesterolaemia

Founder vs. non-founder BRCA1/2 pathogenic alleles: the analysis of Belarusian breast and ovarian cancer patients and review of other studies on ethnically homogenous populations

Fine mapping of a gene responsible for regulating dietary cholesterol absorption; founder effects underlie cases of phytosterolaemia in multiple communities.

Dutch Founder SDHB Exon 3 Deletion in Patients with Pheochromocytoma-Paraganglioma in South Africa

Brain Sciences, Vol. 12, Pages 517: Clinical Characterization and Founder Effect Analysis in Chinese Patients with Phospholipase A2-Associated Neurodegeneration

Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population.

Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population.

Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population.

Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population.

Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population.

Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population.

Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population.

Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population.

Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population.

Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population.

Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population.

Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population.

Distribution and medical impact of loss-of-function variants in the Finnish founder population

Genetic burden linked to founder effects in Saguenay-Lac-Saint-Jean illustrates the importance of genetic screening test availability

Genetic burden linked to founder effects in Saguenay-Lac-Saint-Jean illustrates the importance of genetic screening test availability

Genetic burden linked to founder effects in Saguenay-Lac-Saint-Jean illustrates the importance of genetic screening test availability

Genes, Vol. 13, Pages 213: The SNP-Based Profiling of Montecristo Feral Goat Populations Reveals a History of Isolation, Bottlenecks, and the Effects of Management

Genes, Vol. 13, Pages 213: The SNP-Based Profiling of Montecristo Feral Goat Populations Reveals a History of Isolation, Bottlenecks, and the Effects of Management

Antithetic effect of interferon-α on cell-free and cell-to-cell HIV-1 infection

A FOUNDER EFFECT LED EARLY SARS-COV-2 TRANSMISSION IN SPAIN.

Haplotype analysis and possible founder effect at the R778L mutation of the ATP7B gene in ...

Detection of the founder effect in Finnish CADASIL families

Detection of the founder effect in Finnish CADASIL families

Genome-wide selection signatures reveal widespread synergistic effects of culture conditions and temperature stress in Drosophila melanogaster

Investigation of founder effects for the Thr377Met Myocilin mutation in glaucoma families from differing ethnic backgrounds.

Major histocompatibility complex (MHC)-linked microsatellite markers in a founder population.

The genome-wide landscape of copy number variations in the MUSGEN study provides evidence for a founder effect in the isolated Finnish population.

Boricua Founder Variant in FRRS1L Causes Epileptic Encephalopathy With Hyperkinetic Movements

The fragile X syndrome in Finland: demonstration of a founder effect by analysis of microsatellite haplotypes

Genes, Vol. 13, Pages 675: Predominant Founder Effect among Recurrent Pathogenic Variants for an X-Linked Disorder

Genes, Vol. 13, Pages 675: Predominant Founder Effect among Recurrent Pathogenic Variants for an X-Linked Disorder

Benefits of Newborn Screening for Vitamin D-Dependant Rickets Type 1A in a Founder Population

The Genome-wide Patterns of Variation Expose Significant Substructure in a Founder Population.

The Genome-wide Patterns of Variation Expose Significant Substructure in a Founder Population.

The Genome-wide Patterns of Variation Expose Significant Substructure in a Founder Population.

The genome-wide patterns of variation expose significant substructure in a founder population.

Follow-up of 316 Molecularly Defined Pediatric Long QT Syndrome Patients - Clinical Course, Treatments and Side Effects.

Follow-up of 316 Molecularly Defined Pediatric Long QT Syndrome Patients - Clinical Course, Treatments and Side Effects.

The effects of a HTR2B stop codon and testosterone on energy metabolism and beta cell function among antisocial Finnish males.